ID: ALA5290216

Max Phase: Preclinical

Molecular Formula: C22H18N4

Molecular Weight: 338.41

Associated Items:

Representations

Canonical SMILES:  CCn1c2ccccc2c2cc(-n3nncc3-c3ccccc3)ccc21

Standard InChI:  InChI=1S/C22H18N4/c1-2-25-20-11-7-6-10-18(20)19-14-17(12-13-21(19)25)26-22(15-23-24-26)16-8-4-3-5-9-16/h3-15H,2H2,1H3

Standard InChI Key:  LJCANTASZGYJLG-UHFFFAOYSA-N

Associated Targets(Human)

Ras-related C3 botulinum toxin substrate 1 221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cell division control protein 42 homolog 123 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 338.41Molecular Weight (Monoisotopic): 338.1531AlogP: 5.06#Rotatable Bonds: 3
Polar Surface Area: 35.64Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 0.27CX LogP: 4.94CX LogD: 4.94
Aromatic Rings: 5Heavy Atoms: 26QED Weighted: 0.46Np Likeness Score: -1.37

References

1. Gendaszewska-Darmach E, Garstka MA, Błażewska KM..  (2021)  Targeting Small GTPases and Their Prenylation in Diabetes Mellitus.,  64  (14.0): [PMID:34236862] [10.1021/acs.jmedchem.1c00410]

Source